ResMed Inc (RSMDF) stock
RSMDFOTCSurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RMD
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Aug 13, 2026Score 21/3011% below fair value
$22.61+0.00 (0.00%)
Close on Oct 19, 2026Market cap $33.17BP/E 22.0Yield 1.04%
ResMed total assets
Total assets on the balance sheet at the end of each period.
ResMed's total assets was $8.97B at Jun 30, 2026. For fiscal 2026 it was $8.97B, up 9.7% from the year before. Over ten years it grew 10.7% a year on average. The highest annual figure on record is $8.97B in fiscal 2026.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $8.97B | +9.7% |
| FY2025 | Jun 30, 2025 | $8.17B | +18.9% |
| FY2024 | Jun 30, 2024 | $6.87B | +1.8% |
| FY2023 | Jun 30, 2023 | $6.75B | +32.5% |
| FY2022 | Jun 30, 2022 | $5.10B | +7.8% |
| FY2021 | Jun 30, 2021 | $4.73B | +3.1% |
| FY2020 | Jun 30, 2020 | $4.59B | +11.7% |
| FY2019 | Jun 30, 2019 | $4.11B | +34.1% |
| FY2018 | Jun 30, 2018 | $3.06B | -11.7% |
| FY2017 | Jun 30, 2017 | $3.47B | +6.5% |
| FY2016 | Jun 30, 2016 | $3.26B | +49.3% |
| FY2015 | Jun 30, 2015 | $2.18B | -7.6% |
| FY2014 | Jun 30, 2014 | $2.36B | +6.8% |
| FY2013 | Jun 30, 2013 | $2.21B | +3.4% |
| FY2012 | Jun 30, 2012 | $2.14B | +3.3% |
| FY2011 | Jun 30, 2011 | $2.07B | +27.2% |
| FY2010 | Jun 30, 2010 | $1.63B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026 | Jun 30, 2026 | $8.97B | +9.7% |
| Q3 FY2026 | Mar 31, 2026 | $8.78B | +16.1% |
| Q2 FY2026 | Dec 31, 2025 | $8.50B | +19.1% |
| Q1 FY2026 | Sep 30, 2025 | $8.31B | +15.0% |
| Q4 FY2025 | Jun 30, 2025 | $8.17B | +18.9% |
| Q3 FY2025 | Mar 31, 2025 | $7.57B | +11.0% |
| Q2 FY2025 | Dec 31, 2024 | $7.14B | +3.4% |
| Q1 FY2025 | Sep 30, 2024 | $7.22B | +7.1% |
| Q4 FY2024 | Jun 30, 2024 | $6.87B | +1.8% |
| Q3 FY2024 | Mar 31, 2024 | $6.81B | +1.5% |
| Q2 FY2024 | Dec 31, 2023 | $6.91B | +3.4% |
| Q1 FY2024 | Sep 30, 2023 | $6.74B | +30.2% |
| Q4 FY2023 | Jun 30, 2023 | $6.75B | +32.5% |
| Q3 FY2023 | Mar 31, 2023 | $6.71B | +36.9% |
| Q2 FY2023 | Dec 31, 2022 | $6.68B | +41.0% |
| Q1 FY2023 | Sep 30, 2022 | $5.18B | +9.5% |
| Q4 FY2022 | Jun 30, 2022 | $5.10B | +7.8% |
| Q3 FY2022 | Mar 31, 2022 | $4.91B | +7.0% |
| Q2 FY2022 | Dec 31, 2021 | $4.73B | +3.5% |
| Q1 FY2022 | Sep 30, 2021 | $4.73B | +2.3% |
| Q4 FY2021 | Jun 30, 2021 | $4.73B | +3.1% |
| Q3 FY2021 | Mar 31, 2021 | $4.59B | +1.7% |
| Q2 FY2021 | Dec 31, 2020 | $4.57B | +5.0% |
| Q1 FY2021 | Sep 30, 2020 | $4.62B | +11.2% |
| Q4 FY2020 | Jun 30, 2020 | $4.59B | +11.7% |
| Q3 FY2020 | Mar 31, 2020 | $4.51B | +10.1% |
| Q2 FY2020 | Dec 31, 2019 | $4.35B | +12.8% |
| Q1 FY2020 | Sep 30, 2019 | $4.15B | +35.4% |
| Q4 FY2019 | Jun 30, 2019 | $4.11B | +34.1% |
| Q3 FY2019 | Mar 31, 2019 | $4.10B | +16.0% |
| Q2 FY2019 | Dec 31, 2018 | $3.86B | +8.3% |
| Q1 FY2019 | Sep 30, 2018 | $3.07B | -12.1% |
| Q4 FY2018 | Jun 30, 2018 | $3.06B | -11.7% |
| Q3 FY2018 | Mar 31, 2018 | $3.53B | +3.3% |
| Q2 FY2018 | Dec 31, 2017 | $3.56B | +7.3% |
| Q1 FY2018 | Sep 30, 2017 | $3.49B | +5.0% |
| Q4 FY2017 | Jun 30, 2017 | $3.47B | – |
| Q3 FY2017 | Mar 31, 2017 | $3.42B | – |
| Q2 FY2017 | Dec 31, 2016 | $3.32B | – |
| Q1 FY2017 | Sep 30, 2016 | $3.32B | – |